BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29407976)

  • 1. Regioselective synthesis of 3,4-diaryl-5-unsubstituted isoxazoles, analogues of natural cytostatic combretastatin A4.
    Chernysheva NB; Maksimenko AS; Andreyanov FA; Kislyi VP; Strelenko YA; Khrustalev VN; Semenova MN; Semenov VV
    Eur J Med Chem; 2018 Feb; 146():511-518. PubMed ID: 29407976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(5-)-Amino-o-diarylisoxazoles: regioselective synthesis and antitubulin activity.
    Tsyganov DV; Khrustalev VN; Konyushkin LD; Raihstat MM; Firgang SI; Semenov RV; Kiselyov AS; Semenova MN; Semenov VV
    Eur J Med Chem; 2014 Feb; 73():112-25. PubMed ID: 24388833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents.
    Semenova MN; Demchuk DV; Tsyganov DV; Chernysheva NB; Samet AV; Silyanova EA; Kislyi VP; Maksimenko AS; Varakutin AE; Konyushkin LD; Raihstat MM; Kiselyov AS; Semenov VV
    ACS Comb Sci; 2018 Dec; 20(12):700-721. PubMed ID: 30452225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
    Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
    Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
    Demchuk DV; Samet AV; Chernysheva NB; Ushkarov VI; Stashina GA; Konyushkin LD; Raihstat MM; Firgang SI; Philchenkov AA; Zavelevich MP; Kuiava LM; Chekhun VF; Blokhin DY; Kiselyov AS; Semenova MN; Semenov VV
    Bioorg Med Chem; 2014 Jan; 22(2):738-55. PubMed ID: 24387982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing novel dihydrofuran and dihydroisoxazole analogues of isocombretastatin-4 as tubulin polymerization inhibitors through [3+2] reactions.
    Song MY; Cao CY; He QR; Dong QM; Li D; Tang JJ; Gao JM
    Bioorg Med Chem; 2017 Oct; 25(20):5290-5302. PubMed ID: 28803799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling and target synthesis of monomethoxy-substituted o-diphenylisoxazoles with unexpectedly high antimitotic microtubule destabilizing activity.
    Stroylov VS; Svitanko IV; Maksimenko AS; Kislyi VP; Semenova MN; Semenov VV
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127608. PubMed ID: 33038545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
    Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
    Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo evaluation of polyalkoxy substituted 4H-chromenes and oxa-podophyllotoxins as microtubule destabilizing agents in the phenotypic sea urchin embryo assay.
    Semenova MN; Tsyganov DV; Malyshev OR; Ershov OV; Bardasov IN; Semenov RV; Kiselyov AS; Semenov VV
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3914-8. PubMed ID: 24997684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
    Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
    Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytostatic Activity of Combretastatin A-4 Derivatives in an In Vitro System.
    Plyutinskaya AD; Nemtsova ER; Pankratov AA; Shegai PV; Krylov SS; Iskandarova VN; Maksimenko AS; Demchuk DV; Kuptsova TS; Semenova MN; Semenov VV
    Bull Exp Biol Med; 2022 Dec; 174(2):221-225. PubMed ID: 36600040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.
    Md Tohid SF; Ziedan NI; Stefanelli F; Fogli S; Westwell AD
    Eur J Med Chem; 2012 Oct; 56():263-70. PubMed ID: 22955095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic activities of 4,5-diarylisoxazoles.
    Sun CM; Lin LG; Yu HJ; Cheng CY; Tsai YC; Chu CW; Din YH; Chau YP; Don MJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1078-81. PubMed ID: 17127061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.